Copper IUDs

Healthcare and Consumer Chief Marketing Officer Ann Peets Joins Chief Outsiders

Retrieved on: 
Wednesday, October 12, 2022
Giant, Health, Marketing, Growth, VP, BD (company), Inc. (magazine), Global, Wellesley College, MBA, Outsider, Epinephrine autoinjector, Copper IUDs, University, IUD, GlobeNewswire, Nicotine, Â, Awareness, Fraction, GLOBE, Amazon, Amlodipine/benazepril, CMO, Chief executive officer, Peets (surname), CMOS, Tablet, Hotel manager, Sales, Management

CHARLESTON, SC, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Leading pharmaceutical, medical device, and consumer Chief Marketing Officer Ann Peets has joined the team of more than 120 fractional Chief Marketing Officers (CMOs) at Chief Outsiders, one of the nations top consulting agencies focused on strategic business growth.

Key Points: 
  • CHARLESTON, SC, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Leading pharmaceutical, medical device, and consumer Chief Marketing Officer Ann Peets has joined the team of more than 120 fractional Chief Marketing Officers (CMOs) at Chief Outsiders, one of the nations top consulting agencies focused on strategic business growth.
  • Peets, a marketing executive with broad-based experience over the pharmaceutical, medical device, over-the-counter and consumer segments of healthcare, joins the team of battle-tested CMOs who are available for fractional client engagements with the mid-market businesses that comprise Chief Outsiders client base.
  • As the Global VP of Marketing at Safeguard Medical, Peets leveraged a new wave of consumer attitude coupled with a dual healthcare professional and comprehensive direct-to-consumer go-to-market strategy for Paragard, a hormone-free IUD.
  • For additional information about the companies who trust Chief Outsiders as their premier source for business growth acceleration, click here .

Keller Lenkner Partners Nicole Berg & Seth Meyer Named Crain's Chicago Business 2021 Notable Rising Stars in Law

Retrieved on: 
Tuesday, September 7, 2021

CHICAGO, Sept. 7, 2021 /PRNewswire/ -- Keller Lenkner LLC Partners Nicole Berg and Seth Meyer have been named Crain's Chicago Business 2021 Notable Rising Stars in Law .

Key Points: 
  • CHICAGO, Sept. 7, 2021 /PRNewswire/ -- Keller Lenkner LLC Partners Nicole Berg and Seth Meyer have been named Crain's Chicago Business 2021 Notable Rising Stars in Law .
  • She was appointed to the Law & Briefing Subcommittee in the 3M Combat Arms Earplugs MDL, the largest federal MDL in history.
  • Berg also prosecutes cases on behalf of Keller Lenkner clients in those and other matters.
  • ABOUT KELLER LENKNER: Keller Lenkner LLC represents plaintiffs in complex litigation matters in federal and state courts throughout the nation.

Quintessa Marketing Announces Mass Tort Lead Generation

Retrieved on: 
Thursday, August 26, 2021
Roundup (herbicide), Bayer, Juul, Survival, Social Security, Parkinson's disease, Disability, Lymphoma, Copper IUDs, MDL, Research, Liver failure, Clearview AI, Class action, Pentosan polysulfate, Kidney failure, Marketing, Farmer, Heart failure, Pharmaceutical industry

Today, Quintessa Marketing announced the addition of mass tort lead generation to their national attorney client base.

Key Points: 
  • Today, Quintessa Marketing announced the addition of mass tort lead generation to their national attorney client base.
  • With all these classes to fill, Quintessa Marketing is poised to accelerate the connection between affected consumers and attorneys to reach faster settlements, leveraging proven and proprietary lead generation strategies.
  • Quintessa Marketing is launching its Mass Tort lead generation campaigns in September with the eyes of attorneys and firms across the nation anxiously awaiting the results.
  • Quintessa Marketing is a legal marketing firm with its headquarters based in Oklahoma City, Oklahoma.

Paragard IUD Linked to Breakage, Serious Surgeries to Remove Pieces, Reports A Case for Women

Retrieved on: 
Thursday, May 20, 2021
Professional services, Health, Medical devices, Consumer, Women, Surgery, Legal, Medicine, Clinical medicine, Medical specialties, Copper IUDs, Sterilization, Intrauterine device, Hormonal IUDs, Hysterectomy

b'Thousands of women have filed lawsuits against the manufacturers of Paragard, the only non-hormonal IUD on the market, after being forced to undergo serious surgeries such as hysteroscopies, hysterectomies, laparoscopies or laparoptomies to remove broken pieces of the device, reports A Case for Women.

Key Points: 
  • b'Thousands of women have filed lawsuits against the manufacturers of Paragard, the only non-hormonal IUD on the market, after being forced to undergo serious surgeries such as hysteroscopies, hysterectomies, laparoscopies or laparoptomies to remove broken pieces of the device, reports A Case for Women.
  • (Photo: Business Wire)\nThe lawsuit alleges the Paragard device has manufacturing and design defects that promote breakage.
  • However, there is now evidence that the device may have a serious defect that is causing dangerous health problems for women.
  • Learn more about A Case for Women at https://acaseforwomen.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210520005965/en/\n'

OCON's Pioneering IUB™ Ballerine® Femtech Applauded by Frost & Sullivan

Retrieved on: 
Friday, April 23, 2021
Typography, Typefaces, Medical technology, Women's health, Intrauterine device, Femtech, Health sciences, Copper IUDs, Myriad, Ocon

Its safety, quality, and comfort advantages have already earned it a global customer base," said Suchismita Das, Industry Analyst.

Key Points: 
  • Its safety, quality, and comfort advantages have already earned it a global customer base," said Suchismita Das, Industry Analyst.
  • "\nUnderstanding the myriad of issues women face with rigid T-shaped IUDs, OCON created the IUB Ballerine to be uniquely spherical and small (15 mm in diameter).
  • Its exceptional properties have increased its acceptance rates among women of different age groups and position the company for continued domination of the femtech space.
  • "\nEach year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products, but also enables the development of new products and applications.

OCON's Pioneering IUB™ Ballerine® Femtech Applauded by Frost & Sullivan

Retrieved on: 
Friday, April 23, 2021
Typography, Typefaces, Medical technology, Women's health, Intrauterine device, Femtech, Health sciences, Copper IUDs, Myriad, Ocon

Its safety, quality, and comfort advantages have already earned it a global customer base," said Suchismita Das, Industry Analyst.

Key Points: 
  • Its safety, quality, and comfort advantages have already earned it a global customer base," said Suchismita Das, Industry Analyst.
  • "\nUnderstanding the myriad of issues women face with rigid T-shaped IUDs, OCON created the IUB Ballerine to be uniquely spherical and small (15 mm in diameter).
  • Its exceptional properties have increased its acceptance rates among women of different age groups and position the company for continued domination of the femtech space.
  • "\nEach year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products, but also enables the development of new products and applications.

Cory Watson Attorney Andy Jones Named to Plaintiffs' Steering Committee for Paragard Multidistrict Litigation

Retrieved on: 
Monday, February 22, 2021
Jurisdiction, Multidistrict litigation, United States civil procedure, United States law, MDL, Intrauterine device, Copper IUDs, Government, Law

BIRMINGHAM, Ala., Feb. 22, 2021 /PRNewswire-PRWeb/ -- Cory Watson attorney Andy Jones has been named to the Plaintiffs' Steering Committee (PSC) for In Re: Paragard IUD Products Liability Litigation; the multidistrict litigation involving serious complications linked to the Paragard IUD.

Key Points: 
  • BIRMINGHAM, Ala., Feb. 22, 2021 /PRNewswire-PRWeb/ -- Cory Watson attorney Andy Jones has been named to the Plaintiffs' Steering Committee (PSC) for In Re: Paragard IUD Products Liability Litigation; the multidistrict litigation involving serious complications linked to the Paragard IUD.
  • "It is a tremendous honor to serve among a highly talented, passionate group of attorneys as we pursue this nationwide litigation," said Jones.
  • Judicial Panel on Multidistrict Litigation established MDL 2974 in December 2020, consolidating cases involving Paragard in the United States District Court for the Northern District of Georgia.
  • Cory Watson Attorneys is a nationally-recognized personal injury law firm with offices in Birmingham, Alabama as well as Memphis, and Nashville, Tennessee.

Keller Lenkner's Nicole Berg Appointed to Plaintiffs' Executive Committee for Paragard IUD Products Liability Litigation MDL

Retrieved on: 
Friday, February 19, 2021
Drugs, Health sciences, Pharmacology, Intrauterine device, Copper IUDs, Ranitidine

CHICAGO, Feb. 19, 2021 /PRNewswire/ -- Keller Lenkner LLC Partner Nicole Berg has been appointed to the Plaintiffs' Executive Committee for the Paragard IUD Products Liability Litigation MDL.

Key Points: 
  • CHICAGO, Feb. 19, 2021 /PRNewswire/ -- Keller Lenkner LLC Partner Nicole Berg has been appointed to the Plaintiffs' Executive Committee for the Paragard IUD Products Liability Litigation MDL.
  • The plaintiffs allege that their Paragard IUDs broke apart, leaving behind pieces of the device, which sometimes embedded in their uterus.
  • In addition to Berg's two leadership roles, Keller Lenkner Partner Ashley Keller chairs the Law & Briefing Committee in the Zantac (Ranitidine) Products Liability Litigation, and Associate Ashley Barriere serves on the Plaintiffs' Steering Committee and leads the Law & Briefing Subcommittee for the Onglyza and Kombiglyze XR Products Liability Litigation.
  • ABOUT KELLER LENKNER: Keller Lenkner LLC represents plaintiffs in complex litigation matters in federal and state courts throughout the nation.

Rhia Ventures Invests in OCON Healthcare's Ballerine®, the first ever 3D spherical copper intrauterine contraceptive with a superior safety profile, a breakthrough in women's hormone-free birth control options

Retrieved on: 
Friday, December 18, 2020
Health, Articles, Intrauterine device, Copper IUDs, Abnormal uterine bleeding, Vaginal bleeding, Birth control, Health equity

SAN FRANCISCO, Dec. 18, 2020 /PRNewswire/ --Rhia Ventures invested in Israeli-based OCON Healthcare to assist the US launch of Ballerine, the first and only 3D spherical copper IUBTM (Intrauterine Ball).

Key Points: 
  • SAN FRANCISCO, Dec. 18, 2020 /PRNewswire/ --Rhia Ventures invested in Israeli-based OCON Healthcare to assist the US launch of Ballerine, the first and only 3D spherical copper IUBTM (Intrauterine Ball).
  • The financing will also help expand Phase II clinical trials for OCON's SEADTM product, which offers point-of-care therapy for abnormal uterine bleeding (AUB).
  • Rhia Ventures invests in OCON Healthcare to bring Ballerine, a breakthrough, safer IUD contraceptive to women in the US.
  • Rhia Ventures also invests in innovations that improve outcomes and reduce health disparities in maternal health.

ASPIVIX Reports Positive First-in-Women Results Using Novel Suction-based Cervical Device in IUD Procedures

Retrieved on: 
Thursday, December 10, 2020
Drugs, Women's health, Intrauterine device, Surgical instruments, Birth control, Tenaculum, Cervix, Medroxyprogesterone acetate, Copper IUDs

The ADVANCE Women (Atraumatic Device using VAcuum Technology for CErvical Procedures in WOMEN) Phase I trial was conducted at Lausanne University Hospital (CHUV) by Prof. Patrice Mathevet, an expert in innovative gynecological surgical approaches, and his team.

Key Points: 
  • The ADVANCE Women (Atraumatic Device using VAcuum Technology for CErvical Procedures in WOMEN) Phase I trial was conducted at Lausanne University Hospital (CHUV) by Prof. Patrice Mathevet, an expert in innovative gynecological surgical approaches, and his team.
  • The two-phase ADVANCE Women trial is assessing the usability, efficacy and safety of the investigational CAREVIX, an innovative, soft-suction cervical device designed as a modern and gentler alternative to a tenaculum to stabilize the cervix for the insertion of an Intrauterine Device (IUD) for contraception.
  • "The innovative CAREVIX device is easy-to-use, and I am encouraged by its potential to enhance women's overall experience with an interest in IUD placement."
  • ASPIVIX SA is a privately held medical device company based in Renens, Switzerland, dedicated to developing modern and gentle gynecological solutions that advance women's healthcare.